Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Name: Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers
Published: 2019
License: Public Domain

M.D. Anderson Cancer Center · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

locally advanced adrenal gland pheochromocytoma, locally advanced paraganglioma, metastatic adrenal gland pheochromocytoma, metastatic paraganglioma, metastatic parathyroid gland carcinoma, pituitary gland carcinoma, somatostatin receptor positive, stage iii thyroid gland medullary carcinoma ajcc v8, stage iv thyroid gland medullary carcinoma ajcc v8, stage iva thyroid gland medullary carcinoma ajcc v8, stage ivb thyroid gland medullary carcinoma ajcc v8, stage ivc thyroid gland medullary carcinoma ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 802520
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.